2nd Quarter - Report
HOSPIRA, INC. for HOSPIRA INC
Firm
Client
Income
—
Expenses
$227,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
S. 3125 R& D Tax Extender
| Lobbyist | Covered position, as disclosed |
|---|---|
| LORI NEAL BOWMAN | — |
| JULIANA REED | — |
Health Issues HCR
HR 1038 / S 623 Access to Life-Saving Medicine Act HR 1956 Patient Protection and Innovative Biologic Medicines Act HR 5629 The Pathway for Biosimilars Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| LORI NEAL BOWMAN | — |
| JULIANA REED | — |
Consumer Issues/Safety/Products CSP
HR 3610 The Food and Drug Import Safety Bill JR 5839 Safeguarding America's Pharmaceutical Act of 2008
| Lobbyist | Covered position, as disclosed |
|---|---|
| LORI NEAL BOWMAN | — |
| JULIANA REED | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.